BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su J, Zhu H, Yao Y, Duan Y. Antiangiogenic Therapy: Challenges and Future Directions. CTMC 2021;21:87-9. [DOI: 10.2174/156802662102201211113414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Marzo T, Ferraro G, Cucci LM, Pratesi A, Hansson Ö, Satriano C, Merlino A, La Mendola D. Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells. J Inorg Biochem 2022;226:111657. [PMID: 34784565 DOI: 10.1016/j.jinorgbio.2021.111657] [Reference Citation Analysis]
2 Wang Y, Sun M, Wang Y, Qin J, Zhang Y, Pang Y, Yao Y, Yang H, Duan Y. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency. Eur J Med Chem 2021;225:113790. [PMID: 34454126 DOI: 10.1016/j.ejmech.2021.113790] [Reference Citation Analysis]
3 Yao Y, Huang T, Wang Y, Wang L, Feng S, Cheng W, Yang L, Duan Y. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors. J Enzyme Inhib Med Chem 2022;37:652-65. [PMID: 35109719 DOI: 10.1080/14756366.2022.2032688] [Reference Citation Analysis]